Skip to main content
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

Popular Anxiety Medication Recalled Nationwide over Potential Quality Issue

The voluntary recall covers 1 lot of 3 mg extended-release tablets after the FDA said the pills failed dissolution tests.

  • Viatris Inc. initiated a nationwide recall for lot #8177156 of 3mg Xanax XR extended-release tablets, removing the product from circulation following identification of quality control defects.
  • According to the Food and Drug Administration, the drug was recalled because it "failed dissolution specifications," a defect health officials noted could mean the pills are less effective or fail to release the correct dosage.
  • Distributed nationwide between August 27, 2024, and May 29, 2025, the affected bottles carry an expiration date of February 28, 2027, according to the California State Board of Pharmacy.
  • The FDA designated this as a Class II recall, which means "use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences."
  • Xanax is primarily used to treat anxiety and panic disorders as a benzodiazepine that enhances neurotransmitter activity; Viatris did not immediately respond to requests for comment regarding the recall initiated last month.
Insights by Ground AI
Podcasts & Opinions

87 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 85% of the sources are Center
85% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

NBC San Diego broke the news in San Diego, United States on Wednesday, April 15, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal